Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 42% Undervaluation?
Siemens Healthcare Announces Second Quarter Earnings Report, Steady Progress Towards Achieving FY2024 Goals
ERLANGEN, May 7, 2024/PRNewswire/ -- Siemens Healthcare today released its results report for the second quarter of the 2024 fiscal year ending March 31, 2024. The equipment order shipment ratio in the second quarter of FY2024 reached 1.08. Compared with the excellent performance in the same period last year, comparable revenue increased by 3%; excluding the rapid COVID-19 antigen testing business, comparable revenue increased 11.7%. Compared with the strong performance in the same period last year, the imaging diagnosis business increased 2.6% in comparable revenue, and the adjusted profit margin before interest and tax was 20.2%, and the laboratory diagnosis business was comparable
Siemens Healthineers Backs Outlook After Surge in Net Profit
By Helena Smolak Siemens Healthineers posted a sharp increase in net profit for its second quarter on lower expenses and backed its full-year outlook. The German healthcare company said Tuesday that
Correction to Siemens Healthineers Article on May 10, 2023
Siemens Healthineers posted a net profit of 105 million euros for the quarter ended March 31, 2023. "Siemens Healthineers 2Q Earnings, Revenue Hit by Waning Covid-19 Test Sales," at 0522 GMT on May 10
Siemens Healthineers AG (ETR:SHL) Stock Most Popular Amongst Public Companies Who Own 76%, While Individual Investors Hold 13%
Together With Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024
PALO ALTO, Calif., May 2, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and th
Siemens Healthineers AG Goes Ex Dividend Tomorrow
Siemens Healthcare joins hands with the CHESS Liver Health Alliance and the National Innovation Platform to jointly promote industry-university-research-medical innovation cooperation
The two sides plan to launch industry-university-research transformation cooperation in liver angiology technology and a team of academicians to jointly unveil the “Medical Engineering Cross-Innovation Workstation”. The scope of future cooperation will be further expanded to include the fields of accurate diagnosis and treatment of chronic liver disease, Hangzhou, April 15, 2024/PRNewswire/ -- Recently, empowered by Southeast University's National Medical Research, Obstetrics and Education Integration Innovation Platform, CHESS Liver Health Alliance and Siemens Healthcare will jointly unveil the “Medical Engineering Cross-Innovation Workstation”.” The “Medical Engineering Cross-Innovation Workstation” will be launched at Siemens Healthcare's Shanghai Innovation Center. The preliminary plans of the two sides revolve around the subject of chronic liver disease
Siemens Healthineers Commit to Increase Localization in China
Germany-based Siemens Healthineers pledged to deepen localization in China with an increasing number of localized products and the continuous localization of its supply chain as they have noticed the capability of independent innovation from the country, said the company's top executive for China.
Investing in Siemens Healthineers (ETR:SHL) Five Years Ago Would Have Delivered You a 57% Gain
SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS To Go Ex-Dividend On April 19th, 2024 With 0.51638 USD Dividend Per Share
March 27th - $SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS(SMMNY.US)$ is trading ex-dividend on April 19th, 2024. Shareholders of record on April 22nd, 2024 will receive 0.51638 USD di
Siemens Healthcare grew strongly in the first quarter, laying a solid foundation for the 2024 fiscal year
ERLANGEN, Germany, Feb. 1, 2024/PRNewswire/ -- Siemens Healthcare today released its results report for the first quarter of the 2024 fiscal year ending December 31, 2023. The equipment order shipment ratio in the first quarter of FY2024 was as high as 1.14, excluding the rapid COVID-19 antigen testing business, which was a strong increase of 7.0%; taking into account the rapid COVID-19 antigen testing business that had been terminated in the fourth quarter of FY2023, comparable revenue increased 5.7%, and the imaging business increased 5.3% compared to revenue; due to the adverse effects of the short-term business portfolio, adjusted profit before interest and tax
Stock Leaders for 2030 in Health Tech - UBS
GE HealthCare Falls as UBS Cut to Sell on Valuation
Siemens Healthcare showcased the enormous potential of generative AI in the medical field at the 2023 RSNA
The industry is the first in the industry to combine clinical images with diagnostic reports through generative AI, generative AI is expected to achieve a huge leap in diagnostic efficiency Chicago November 27, 2023//PRNewswire/ -- The boom in software such as ChatGPT has taken the world by storm, showing that the potential of generative AI is that it can not only analyze existing data sets, but also create new content. At the 2023 Annual Meeting of the Radiological Society of North America (RSNA), Siemens Healthcare showcased innovative ideas and technology prototypes based on generative AI. Unlike other companies that focus on text or image generation, Siemens Healthcare has taken a fresh approach
Siemens Healthcare confirms participation in the 7th China International Import Expo
SHANGHAI, November 8, 2023/PRNewswire/ -- On November 8, Siemens Healthcare signed a formal contract with the China International Import Expo Bureau to confirm participation in the 7th China International Import Expo. Liu Fuxue, Deputy Director of the China International Import Expo Bureau (second from left) and Siemens Healthcare Greater China President Wang Hao (second from right) attended and witnessed the signing ceremony
Siemens Healthcare performed strongly in the fourth quarter and ended fiscal year 2023 successfully
ERLANGEN, GERMANY, November 8, 2023/PRNewswire/ -- Siemens Healthcare recently released results reports for the fourth quarter of fiscal year 2023 and the full year of fiscal year 2023 and the full year of fiscal year 2023 ending September 30, 2023. FY2023: Revenue growth and earnings per share targets both reached equipment order delivery ratio of 1.15 Excluding the rapid COVID-19 antigen testing business, comparable revenue increased significantly by 8.3%; the rapid COVID-19 antigen testing business was terminated in the fourth quarter. Including this business, comparable revenue increased by 1.2%, and Varian Healthcare's comparable revenue grew strongly by 14.8 percent
Sun Yat-sen Memorial Hospital of Sun Yat-sen University and Siemens Healthcare signed a strategic cooperation agreement at the 6th CIIE
SHANGHAI, November 6, 2023/PRNewswire/ -- Today, at the Siemens Medical booth at the 6th CIIE, Sun Yat-sen Memorial Hospital of Sun Yat-sen University and Siemens Healthcare China signed a strategic cooperation agreement. The two sides will jointly explore the scientific research application and medical transformation of metaverse visual surgery in frontal lateral flap transplantation. Director Fan Song of Oral and Maxillofacial Surgery at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and Wang Chao, Vice President of Siemens Healthcare Greater China, attended the signing ceremony. According to the agreement, Siemens Healthcare will collaborate with Sun Yat-sen Memorial Hospital to develop a positioning and registration tool for anterolateral flap transplantation to achieve metaverse visualization of stocks
Siemens Healthcare exhibited the world's first four-dimensional volumetric intracardiac ultrasound catheter at the 6th Expo
SHANGHAI, November 6, 2023/PRNewswire/ -- At the 6th Expo, Siemens Healthcare exhibited the world's first four-dimensional volumetric intracardiac ultrasound catheter, ACUSON AcuNav Volume [1] (hereinafter referred to as the “four-dimensional ICE catheter”). This ultrasound catheter is a pioneering innovative device in the field of structural heart disease, pioneering changes in surgical procedures for ultrasound in structural heart disease. Siemens Healthcare's four-dimensional volumetric intracardiac ultrasound catheter Today, the world is facing an aging population trend. Various arrhythmic diseases such as valvular heart disease and atrial fibrillation have become important threats to people's health
China Intl Expo Showcases New Cutting Edge Medical Technology
The China International Import Expo, which opened on Sunday, has proven to be a premier platform for companies from around the world to showcase their latest cutting-edge products as proven by the slew of exhibits making their global or regional debut.
No Data